Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

hVIVO (HVO)

Price 29.00p on 28-03-2024 at 17:30:02
Change 0.60p 2.08%
Buy 29.50p
Sell 28.50p
Buy / Sell HVO Shares
Last Trade: Unknown 6,795.00 at 29.50p
Day's Volume: 646,449
Last Close: 29.50p
Open: 28.90p
ISIN: GB00B9275X97
Day's Range 29.00p - 29.50p
52wk Range: 13.75p - 32.00p
Market Capitalisation: £201m
VWAP: 29.1279p
Shares in Issue: 680m

Recent Trades History hVIVO (HVO)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 6,795 29.50p OTC Trade
16:35:35 - 28-Mar-24
Buy* 6,795 29.50p Ordinary
16:35:35 - 28-Mar-24
Buy* 4,031 29.50p Suspected BUY Trade
16:35:09 - 28-Mar-24
Buy* 1,718 29.10p Ordinary
16:26:57 - 28-Mar-24
Buy* 1,000 29.23p Ordinary
16:06:56 - 28-Mar-24
Sell* 3,500 28.81p Ordinary
15:56:15 - 28-Mar-24
Buy* 24,531 29.23p Ordinary
15:54:33 - 28-Mar-24
Sell* 34,164 28.925p Ordinary
15:41:18 - 28-Mar-24
Buy* 3,816 29.28p Ordinary
15:40:36 - 28-Mar-24
Sell* 10,000 28.95p Ordinary
15:40:31 - 28-Mar-24

Share Price History for hVIVO

Time period:
to
Date Open High Low Close Volume

Share News for hVIVO

Investment firm European Green Transition plans listing on AIM

18th Mar 2024 11:23

(Alliance News) - European Green Transition Ltd on Monday said it plans to launch its initial public offering on London's AIM market in early April. Read More

IN BRIEF: hVIVO Chair and non-exec director sell 30.0 million shares

14th Feb 2024 19:55

hVIVO PLC - London-based contract research organisation testing vaccines for infectious and respiratory diseases - Confirms two shareholders, Chair Cathal Friel and Non-Executive Director Brendan Buckley have sold a total around 30.0 million shares in company in a placing at 28 pence per share. Sale represents around 4.4% of the company's share capital. Friel sells around 26.0 million shares with a resulting holding of 3.1%. Buckley sells around 4.0 million shares with a resulting holding of 0.6%. The selling shareholders have agreed with Cavendish and Peel Hunt not to dispose of any further shares for a period of 12 months without the prior written consent of Cavendish and Peel Hunt. Read More

IN BRIEF: hVIVO directors to sell total of 14 million shares

14th Feb 2024 10:46

hVIVO PLC - London-based contract research organisation testing vaccines for infectious and respiratory diseases - Announces that certain directors intend to sell at least 14.0 million shares in total, at 28 pence each. Placing shares represent approximately 25% of the directors' current shareholding. Selling shareholders include investment vehicles of Chair Cathal Friel, and his spouse Pamela Iyer. Read More

hVIVO shares up after "record year" across all metrics

30th Jan 2024 11:39

(Alliance News) - hVIVO PLC on Tuesday set a new revenue target of GBP100 million by 2028, after a "strong financial and operational performance" last year. Read More

hVIVO inks GBP6.3 million deal to test common cold treatment

2nd Jan 2024 10:16

(Alliance News) - hVIVO PLC on Tuesday said it signed a contract worth GBP6.3 million to test a potential treatment for the common cold. Read More

FTSE 100 Latest
Value7,952.62
Change20.64

Login to your account

Forgot Password?

Not Registered